Death after acute withdrawal of intrathecal baclofen: Case report and literature review

被引:67
作者
Green, LB [1 ]
Nelson, VS [1 ]
机构
[1] Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA
来源
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | 1999年 / 80卷 / 12期
关键词
D O I
10.1016/S0003-9993(99)90337-4
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
A 21-year-old man with C1 sensory-incomplete ventilator-dependent quadriplegia, treated with good results with an intrathecal baclofen pump for intractable spasticity since age 17, developed increasing spasticity and fevers when his pump began to malfunction. He became unresponsive and developed hypotension, severe hyperthermia, and ventricular tachycardia that required chemical and electrical cardioversion. Although he was receiving oral baclofen when his pump failed, and he was given an intrathecal bolus of baclofen, he subsequently developed rhabdomyolysis, hepatic enzyme elevations, and a consumptive coagulopathy. Cerebral ischemia then occurred, causing brain death. The literature about intrathecal baclofen withdrawal is reviewed to illustrate that it can be a life-threatening event. (C) 1999 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.
引用
收藏
页码:1600 / 1604
页数:5
相关论文
共 42 条
[1]  
ARMSTRONG RW, 1992, DEV MED CHILD NEUROL, V34, P731
[2]  
ARMSTRONG RW, 1992, DEV MED CHILD NEUROL, V34, P739
[3]  
ARNOLD ES, 1980, AM J PSYCHIAT, V137, P1466
[4]   Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-up [J].
Azouvi, P ;
Mane, M ;
Thiebaut, JB ;
Denys, P ;
RemyNeris, O ;
Bussel, B .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (01) :35-39
[5]  
BARKER I, 1982, LANCET, V2, P556
[6]   BACLOFEN - PRELIMINARY REPORT OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN SPASTICITY [J].
BROGDEN, RN ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1974, 8 (01) :1-14
[7]   INTRATHECAL BACLOFEN FOR INTRACTABLE SPASTICITY OF SPINAL ORIGIN - RESULTS OF A LONG-TERM MULTICENTER STUDY [J].
COFFEY, RJ ;
CAHILL, D ;
STEERS, W ;
PARK, TS ;
ORDIA, J ;
MEYTHALER, J ;
HERMAN, R ;
SHETTER, AG ;
LEVY, R ;
GILL, B ;
SMITH, R ;
WILBERGER, J ;
LOESER, JD ;
CHABAL, C ;
FELER, C ;
ROBERTSON, JT ;
PENN, RD ;
CLARKE, A ;
BURCHIEL, KJ ;
LEIBROCK, LG .
JOURNAL OF NEUROSURGERY, 1993, 78 (02) :226-232
[8]   ADVERSE-EFFECTS SECONDARY TO BACLOFEN WITHDRAWAL [J].
GARABEDIANRUFFALO, SM ;
RUFFALO, RL .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (04) :304-306
[9]   Severe hyperthermia after acute cessation of continuous intrathecal baclofen administration. [J].
Grenier, B ;
Mesli, A ;
Cales, J ;
Castel, JP ;
Maurette, P .
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1996, 15 (05) :659-662
[10]   HALLUCINATIONS AFTER PREOPERATIVE BACLOFEN DISCONTINUATION IN SPINAL-CORD INJURY PATIENTS [J].
HARRISON, SA ;
WOOD, CA .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (10) :747-749